Knockdown of Carboxypeptidase A4 () Inhibits Gastric Cancer Cell Progression Via Cell Cycle Arrest and Apoptosis

Overview

Journal J Gastrointest Oncol

Date 2023 Jan 13

PMID 36636089

Authors

Xinyi Lei

Dong Liu

Danjun Song

Jun Fan

Gaiguo Dai

Litao Yang

Affiliations

Soon will be listed here.

Abstract

Background: Gastric cancer is one of the most prevalent cancers, with a low survival rate at the later stages. Carboxypeptidase A4 () is associated with the aggressiveness and growth in cancer. However, its regulatory role in gastric cancer remains unknown. Therefore, we investigated the role of in gastric cancer progression .

Methods: The human gastric adenocarcinoma cell line (AGS cell line) was used in the present study. knockdown lentiviruses were constructed. Western blot analysis was performed to evaluate the protein expression levels of epithelial-mesenchymal transition (EMT) transcription factors, EMT biomarkers, and proteins involved in the Wnt signaling pathway, mitogen-activated protein kinase (MAPK) signaling pathway, and phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway. Quantitative real-time polymerase chain reaction (qRT-PCR) analysis was carried out to evaluate the mRNA expression level of . The String database was employed for protein-protein interaction (PPI) network analysis. Cell colony formation, proliferation, migration, invasion, apoptosis, and cell cycle analyses were performed using corresponding kits.

Results: is highly expressed in gastric cancer cell lines. Overexpressed was associated with the induction of EMT. Knockdown of inhibited cell colony formation, proliferation, migration, and invasion of gastric cancer cells. Knockdown of also promoted cell apoptosis of gastric cancer cells.

Conclusions: Knockdown of inhibited cell progression via arresting the cell cycle and inducing EMT in gastric cancer.

Citing Articles

Identification of Thyroid Genes Whose Expression Is Altered by Neonatal Irradiation in Rats.

Fujimoto N, Matsuu-Matsuyama M, Nakashima M Int J Mol Sci. 2025; 26(5).

PMID: 40076501 PMC: 11899105. DOI: 10.3390/ijms26051874.

CPA4 as a biomarker promotes the proliferation, migration and metastasis of clear cell renal cell carcinoma cells.

Wang K, Ding Y, Liu Y, Ma M, Wang J, Kou Z J Cell Mol Med. 2024; 28(7):e18165.

PMID: 38494845 PMC: 10945090. DOI: 10.1111/jcmm.18165.

Carboxypeptidase A4 negatively regulates HGS-ETR1/2-induced pyroptosis by forming a positive feedback loop with the AKT signalling pathway.

Wang L, Deng R, Chen S, Tian R, Guo M, Chen Z Cell Death Dis. 2023; 14(12):793.

PMID: 38049405 PMC: 10696061. DOI: 10.1038/s41419-023-06327-5.

References

Kayashima T, Yamasaki K, Yamada T, Sakai H, Miwa N, Ohta T . The novel imprinted carboxypeptidase A4 gene ( CPA4) in the 7q32 imprinting domain. Hum Genet. 2003; 112(3):220-6. DOI: 10.1007/s00439-002-0891-3. View

Vega S, Morales A, Ocana O, Valdes F, Fabregat I, Nieto M . Snail blocks the cell cycle and confers resistance to cell death. Genes Dev. 2004; 18(10):1131-43. PMC: 415638. DOI: 10.1101/gad.294104. View

Sun L, Guo C, Burnett J, Pan J, Yang Z, Ran Y . Association between expression of Carboxypeptidase 4 and stem cell markers and their clinical significance in liver cancer development. J Cancer. 2017; 8(1):111-116. PMC: 5264046. DOI: 10.7150/jca.17060. View

Nieto M . Context-specific roles of EMT programmes in cancer cell dissemination. Nat Cell Biol. 2017; 19(5):416-418. DOI: 10.1038/ncb3520. View

Fu Y, Su L, Cai M, Yao B, Xiao S, He Q . Downregulation of CPA4 inhibits non small-cell lung cancer growth by suppressing the AKT/c-MYC pathway. Mol Carcinog. 2019; 58(11):2026-2039. PMC: 6851884. DOI: 10.1002/mc.23095. View

Wei C, Zhou Y, Xiong Q, Xiong M, Hou Y, Yang X . Comprehensive Analysis of CPA4 as a Poor Prognostic Biomarker Correlated with Immune Cells Infiltration in Bladder Cancer. Biology (Basel). 2021; 10(11). PMC: 8615209. DOI: 10.3390/biology10111143. View

Rawla P, Barsouk A . Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019; 14(1):26-38. PMC: 6444111. DOI: 10.5114/pg.2018.80001. View

Pan H, Pan J, Ji L, Song S, Lv H, Yang Z . Carboxypeptidase A4 promotes cell growth via activating STAT3 and ERK signaling pathways and predicts a poor prognosis in colorectal cancer. Int J Biol Macromol. 2019; 138:125-134. DOI: 10.1016/j.ijbiomac.2019.07.028. View

Yan P, Lyu X, Wang S, Dong S, Zhu Z, Cheng B . Insufficient ablation promotes the metastasis of residual non-small cell lung cancer (NSCLC) cells via upregulating carboxypeptidase A4. Int J Hyperthermia. 2021; 38(1):1037-1051. DOI: 10.1080/02656736.2021.1947530. View

10.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

11.

Nabzdyk C, Chun M, Pradhan L, LoGerfo F . High throughput RNAi assay optimization using adherent cell cytometry. J Transl Med. 2011; 9:48. PMC: 3111359. DOI: 10.1186/1479-5876-9-48. View

12.

Yang Y, Pan X, Lei W, Wang J, Song J . Transforming growth factor-beta1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism. Oncogene. 2006; 25(55):7235-44. DOI: 10.1038/sj.onc.1209712. View

13.

Imani S, Hosseinifard H, Cheng J, Wei C, Fu J . Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis. Sci Rep. 2016; 6:28587. PMC: 4917825. DOI: 10.1038/srep28587. View

14.

Li X, Yu W, Chen Q, Zhuang H, Gao S, Zhao T . LncRNA TUG1 exhibits pro-fibrosis activity in hypertrophic scar through TAK1/YAP/TAZ pathway via miR-27b-3p. Mol Cell Biochem. 2021; 476(8):3009-3020. DOI: 10.1007/s11010-021-04142-0. View

15.

Zhang H, Hao C, Wang H, Shang H, Li Z . Carboxypeptidase A4 promotes proliferation and stem cell characteristics of hepatocellular carcinoma. Int J Exp Pathol. 2019; 100(2):133-138. PMC: 6540673. DOI: 10.1111/iep.12315. View

16.

Shao Q, Zhang Z, Cao R, Zang H, Pei W, Sun T . CPA4 Promotes EMT in Pancreatic Cancer via Stimulating PI3K-AKT-mTOR Signaling. Onco Targets Ther. 2020; 13:8567-8580. PMC: 7457871. DOI: 10.2147/OTT.S257057. View

17.

Ross P, Cheng I, Liu X, Cicek M, Carroll P, Casey G . Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer. BMC Cancer. 2009; 9:69. PMC: 2657151. DOI: 10.1186/1471-2407-9-69. View

18.

Wang Y, Xie Y, Niu Y, Song P, Liu Y, Burnett J . Carboxypeptidase A4 negatively correlates with p53 expression and regulates the stemness of breast cancer cells. Int J Med Sci. 2021; 18(8):1753-1759. PMC: 7976593. DOI: 10.7150/ijms.54954. View

19.

Sun L, Guo C, Yuan H, Burnett J, Pan J, Yang Z . Overexpression of carboxypeptidase A4 (CPA4) is associated with poor prognosis in patients with gastric cancer. Am J Transl Res. 2016; 8(11):5071-5075. PMC: 5126350. View

20.

Lovisa S, LeBleu V, Tampe B, Sugimoto H, Vadnagara K, Carstens J . Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med. 2015; 21(9):998-1009. PMC: 4587560. DOI: 10.1038/nm.3902. View